entertainment -WSS

entertainment

author：explore 2025-09-06 04:14:36 - browse：84819

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： 7 of the most gruesome medical devices in history

hotspot

WSS

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Clinic falsely told dozens they had Alzheimer's, suits say

Doctors have an ethical obligation to be advocates

Inside the culture of fear in the White House science office of Eric Lander

AbbVie dramatically boosts its spending on lobbying

hotspot

entertainment

entertainment

Bright Health sells Medicare Advantage business to Molina

Men with early prostate cancer can safely opt out of treatment

Virginia high school admissions case could be legal follow

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

In age of alternative facts, a scholarly course on calling out crap

New rules on organ donation and transplantation 'will bring chaos'

Malaria cases in Florida and Texas: Here’s what you need to know

CDC backtracks, saying fully vaccinated people can go maskless indoors

What does generative AI mean for health care? We asked experts

Marvel Studios reveals new trailer for 'The Marvels': Watch here

focus

Review: 'Barbie' will hit you like a shot in the heart

PrEP can help anyone prevent HIV. Why do so few people take it?

Malaysia cuts short music fest after British band slams anti

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Our daughter's deadly disease: trisomy 18. We wanted to protect her

hotspot

knowledge

focus

explore